FARALLON CAPITAL MANAGEMENT LLC
Q1 2025 Form 13-F
SAN FRANCISCO, CALIFORNIA
CIK 0000909661
· CRD 107322
· SEC-registered investment adviser
$20.9B Reported Value Total
FARALLON CAPITAL MANAGEMENT, L.L.C. reports 70 total accounts under management (AUM). There are 70 discretionary accounts valued at $48,267,892,000, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
71 funds
· $65.4B gross asset value
Hedge Fund: $65.4B
Source: Form ADV filed 2026-09-23
Reported value
$20.9B
Quarter over quarter
-2.6%
Holdings
144
Top-10 concentration
40.3%
Filing Structure
Reports holdings for
- Farallon Capital Europe LLP · File #028-11719 · Q1 2014 – Q4 2024
- Farallon Capital Europe LLP (not a 13F filer in our records) · Q3 2021 – Q3 2021 · declared by one filing
- Farallon Capital Europe (not a 13F filer in our records) · Q1 2021 – Q2 2021 · declared by one filing
- FARALLON PARTNERS L L C/CA (not a 13F filer in our records) · File #028-06372 · Q2 2013 – Q4 2013
Key People
Form ADV owners & control persons
Andrew James Mclean Spokes
LIMITED PARTNER
Richard Pierre Bollini II
MANAGING MEMBER
Colby Trexler Clark
MANAGING MEMBER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q1 2025 13F record
Q1 2025 13F filing summary
| Period of report | March 31, 2025 |
|---|---|
| Filed | May 15, 2025 |
| Form | 13F-HR |
| Reported value | $20.9B |
| Positions | 144 |
| Change in reported value | -8.5% |
| New positions | 18 |
| Exited positions | 20 |
| Position turnover | 23.2% |
| Top-10 concentration | 40.3% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
82 | $21.7B |
|
Q1 2026 13F
Filed May 15, 2026
|
168 | $19.1B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
148 | $23.1B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
139 | $24.4B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
142 | $23.8B |
|
Q1 2025 13F
Filed May 15, 2025
|
144 | $20.9B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
145 | $22.8B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
158 | $22.8B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
159 | $23.3B |
|
Q1 2024 13F
Filed May 15, 2024
|
168 | $23.6B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
148 | $21.9B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
153 | $61.0B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
158 | $19.9B |
|
Q1 2023 13F
Filed May 15, 2023
|
177 | $33.5B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
226 | $16.9B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
288 | $18.2B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
297 | $18.4B |
|
Q1 2022 13F
Filed May 16, 2022
|
305 | $20.7B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
292 | $20.0B |
|
Q3 2021 13F
Filed Nov 15, 2021
|
290 | $21.4B |
33 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q1 2025
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | SPY P SPDR S&P 500 ETF TR | $1.8B | 8.85% |
| 2 | HES HESS CORP | $866.5M | 4.16% |
| 3 | MSFT MICROSOFT CORP | $858.1M | 4.12% |
| 4 | EXEL EXELIXIS INC | $831.9M | 3.99% |
| 5 | DFS DISCOVER FINL SVCS | $815.9M | 3.91% |
| 6 | UNH UNITEDHEALTH GROUP INC | $784.5M | 3.76% |
| 7 | NTRA NATERA INC | $643.1M | 3.08% |
| 8 | IQV IQVIA HLDGS INC | $601.5M | 2.88% |
| 9 | LNTH LANTHEUS HLDGS INC | $587.9M | 2.82% |
| 10 | ARMK ARAMARK | $560.7M | 2.69% |
| 11 | DIS DISNEY WALT CO | $542.5M | 2.6% |
| 12 | CRM SALESFORCE INC | $527.9M | 2.53% |
| 13 | ADSK AUTODESK INC | $522.9M | 2.51% |
| 14 | INTU INTUIT | $515.9M | 2.47% |
| 15 | TMO THERMO FISHER SCIENTIFIC INC | $515.4M | 2.47% |
| 16 | RVMD REVOLUTION MEDICINES INC | $478.6M | 2.3% |
| 17 | IBB P ISHARES TR | $460.4M | 2.21% |
| 18 | TRU TRANSUNION | $449.2M | 2.15% |
| 19 | NYT NEW YORK TIMES CO | $443.0M | 2.12% |
| 20 | ITCI INTRA-CELLULAR THERAPIES INC | $403.0M | 1.93% |
Values as reported on the Q1 2025 Form 13F. Every position is in the holdings table below.